Desmopressin
| 證據等級: L5 | 預測適應症: 7 個 |
目錄
Desmopressin: Evidence Pack Incomplete — No Repurposing Predictions Available
Summary
Desmopressin is a synthetic analogue of the antidiuretic hormone vasopressin (ADH), widely used internationally for central diabetes insipidus and nocturnal enuresis.
This Evidence Pack contains no TxGNN repurposing predictions (predicted_indications: []) and multiple critical data gaps, making a full repurposing evaluation impossible at this stage.
The recommended action is Hold pending data remediation.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not available (drug not registered in New Zealand; no license data) |
| Predicted New Indication | None (TxGNN returned 0 predictions) |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — Model prediction only (predictions absent) |
| New Zealand Market Status | Not marketed |
| Number of Authorizations | 0 |
| Recommended Decision | Hold |
Safety Considerations
Please refer to the package insert for safety information.
No drug interaction records were found in the DDI database query. TFDA label warnings and contraindications were not retrieved in this data collection cycle.
Conclusion and Next Steps
Decision: Hold
Rationale: The TxGNN pipeline returned zero predicted indications for Desmopressin, and two blocking/high-severity data gaps remain unresolved (MOA and regulatory label text), making it impossible to conduct mechanism-relevance analysis or safety pre-screening.
To proceed, the following is needed:
- [DG001 — Blocking] Retrieve full label text (warnings, contraindications) from the New Zealand Medsafe product monograph or equivalent package insert PDF to enable safety pre-screening
- [DG002 — High] Retrieve mechanism of action from DrugBank API (
DB00035) to support mechanistic plausibility analysis - Re-run TxGNN pipeline after confirming the disease–drug mapping is correctly configured; investigate why
predicted_indicationsreturned an empty array (possible upstream mapping issue forDB00035) - Once predictions are available, re-issue a full Evidence Pack and regenerate this report using the standard template
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.